News
Neurovation Labs Expands IP Portfolio With Patent for Precision Brain Biomarker Detection Technology
NEW YORK CITY, NEW YORK / ACCESS Newswire / April 22, 2025 / Neurovation Labs, Inc., a precision neuroscience biotechnology company targeting physiological biomarkers of Post-traumatic Stress Disorder ...
Science and mental health meet in a UC San Francisco program where clinicians and researchers learn just as much from high ...
Luminopia, Inc., a digital health company pioneering a new class of treatments for neuro-visual disorders, today announced that the U.S. Food & Drug Administration (FDA) cleared its amblyopia ...
They engage local governments and underserved schools, save lives and improve health, protect the environment and push the boundaries of space. And it adds up to an immense direct impact on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results